Website focus group - can you help?
Our new website was designed to provide a clear message about who we are and why we are here. It has a straightforward design to help direct you to the most relevant information for your needs. But there's still work to do...
Learn more
Rallying to the Challenge Online Patient Meeting ‘GBA1 and LRRK2 – from genetic risk to the clinic’
Rallying to the Challenge is a meeting designed for and by people with Parkinson’s, advocates and care partners to explore how the Parkinson’s community can impact and accelerate research. Each year the meeting takes an aspect of Parkinson’s research and discusses how people living with…
Grand Challenges in Parkinson’s Disease: ‘GBA1 and LRRK2 – from genetic risk to the clinic’
The Van Andel Institute (VAI) in Grand Rapids, Michigan annually hosts this scientific conference ‘Grand Challenges in Parkinson’s Disease’ bringing together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s disease research. This research focused symposium will discuss the influence of…
NECTAR 2021
This event brings together scientists, clinicians, patient advocates and industry partners from across Europe and the international community to share the latest research in repairing the damage to the central nervous system as a result of degenerative diseases. Our Deputy Director of Research, Dr Simon…
The Big Splash for Parkinson’s: Positively Parkinson’s swimmers cross the Solent and raise over £39,000
On Sunday 5 September, Peter Burns and Vicky Knight along with ten other swimmers, three of whom are living with Parkinson’s, took on the huge challenge of swimming 5km across the Solent from Gosport on the Hampshire coast to Ryde on the Isle of Wight,…
The 2021 International Linked Clinical Trials Meeting
The International Linked Clinical Trials (iLCT) programme is the flagship drug repurposing initiative of Cure Parkinson’s and Van Andel Institute (VAI) focussed on identifying and clinically testing already available drugs that show potential to slow, stop or reverse the progression of Parkinson’s. Every year the iLCT…